[Dr.Vad]

если у вас есть эта мутация, то тромбоцитаферез предпочтительнее аспирина

A recent consensus of experts on the management of CALR-mutated ET recommends a pure observational approach over aspirin prophylaxis in asymptomatic low-risk ET patients without cardiovascular risk factors, while cytoreduction should be preferred over aspirin for low-risk symptomatic patients with a platelet count of 1,000-1,500x10/9/L.
Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?
[Ссылки доступны только зарегистрированным пользователям ]